Parameters for differentiating vaccine-derived and wild poliovirus strains.
about
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993Mapping the genetic determinants of pathogenicity and plaque phenotype in swine vesicular disease virusSerotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy.Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirusDetection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority.A double-selective tissue culture system for isolation of wild-type poliovirus from sewage applied in a long-term environmental surveillanceIntratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitisMapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirusMolecular and Phenotypic Characterization of a Highly Evolved Type 2 Vaccine-Derived Poliovirus Isolated from Seawater in Brazil, 2014.Advanced environmental surveillance and molecular analyses indicate separate importations rather than endemic circulation of wild type 1 poliovirus in Gaza district in 2002.Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients.Real-time reverse transcription-polymerase chain reaction assays for identification of wild poliovirus 1 & 3Genotype-specific RNA probes for direct identification of wild polioviruses by blot hybridization.High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitisA mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice.Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperatureOral poliovirus vaccine in tropical Africa: greater impact on incidence of paralytic disease than expected from coverage surveys and seroconversion rates.Genetic analysis of the attenuation phenotype of poliovirus type 1.Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine.In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain.A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating.Restricted growth of attenuated poliovirus strains in cultured cells of a human neuroblastoma.Enteroviruses in recreational waters of Northern Ireland.Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.Changes in the EV-A71 Genome through Recombination and Spontaneous Mutations: Impact on Virulence.
P2860
Q24682487-5CDD002A-2AAD-4EAA-A276-D499F3C2A572Q33643104-A7A29A84-73C2-423A-9052-5F6160D203ABQ33655626-4B27FD08-8DD1-4CD9-BFEC-2D3BC41C124CQ33912248-AC3A92D6-6D3B-4502-9F6E-8504D6A5E7B9Q33960667-7D1DCD4E-E776-4436-B601-75F5295911A5Q33984766-9F1BBF75-2536-44AC-B207-A3A2628D2D8AQ34045658-4BBD88D1-5B78-4CE4-8CE5-EEDC67D0345FQ34743074-C0DEF4BD-A163-4943-9362-733B41F6D6F2Q35845480-555E746D-B184-497F-9B55-4E0393184359Q35971462-3F3DD366-3790-4C6D-B4CF-83AD2B604053Q36136750-537D384E-90D5-43F6-87B1-DB84D09558B6Q36328543-90F8D7D3-4A38-4FF1-A7FB-2E3492841B98Q36383680-ABFA28CE-83A5-4C08-AB41-1DC517788497Q36547420-CC7599C0-AA00-44BD-88FA-C71DC8BFD791Q36637959-BCAEE18A-EA38-49C1-B802-401FC873B1D7Q36650977-B5490EA9-38C2-4E64-B052-70C6967BF6B4Q36781751-F2D9C7DC-5BF7-4F77-BBC9-215FB80E8E34Q36784097-283E0185-B436-4D30-B0D8-A5AD06CD0F84Q36799379-7B409572-C89E-4310-B742-8D33F347B508Q36862121-4BF98E5A-B54F-404A-91F4-E9E697C6BD02Q36899024-B49647F8-83AB-4288-8999-0867ADFE0D70Q36899176-9F8E9EAD-D2F2-414E-8BD1-94E7A654D177Q40065544-0DF8F7B3-4855-4442-8F6D-F808928F9298Q40116917-BFEDBDCA-B75E-415D-A7BB-0D16ED283F70Q41623013-B161DF35-EAB1-434A-BB02-5E1C263356A7Q50042232-2E7F12E0-A177-4D86-8A76-AF58E129108CQ55709315-BD2CBD85-02CC-4AC2-89A4-F7917FD4BE15
P2860
Parameters for differentiating vaccine-derived and wild poliovirus strains.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Parameters for differentiating vaccine-derived and wild poliovirus strains.
@en
type
label
Parameters for differentiating vaccine-derived and wild poliovirus strains.
@en
prefLabel
Parameters for differentiating vaccine-derived and wild poliovirus strains.
@en
P2093
P1476
Parameters for differentiating vaccine-derived and wild poliovirus strains.
@en
P2093
P304
P577
1978-01-01T00:00:00Z